Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Is the dip in Atlassian stock a sneaky buy opportunity?: https://www.marketbeat.com/logos/articles/med_20240206110456_is-the-dip-in-atlassian-stock-a-sneaky-buy-opportu.jpg
Is the dip in Atlassian stock a sneaky buy opportunity?

While the S&P 500 index was notching a fresh record last week, shares of software giant Atlassian Corporation (NASDAQ: TEAM) were reeling from a 15% drop. The driver behind the plunge, coming

Is the dip in Atlassian stock a sneaky buy opportunity?: https://www.marketbeat.com/logos/articles/med_20240206110456_is-the-dip-in-atlassian-stock-a-sneaky-buy-opportu.jpg
Is the dip in Atlassian stock a sneaky buy opportunity?

While the S&P 500 index was notching a fresh record last week, shares of software giant Atlassian Corporation (NASDAQ: TEAM) were reeling from a 15% drop. The driver behind the plunge, coming

Caterpillar stock hits new highs; time to ring the register?: https://www.marketbeat.com/logos/articles/med_20240206085138_chart-cat-262024ver001.png
Caterpillar stock hits new highs; time to ring the register?

Caterpillar (NYSE: CAT) stock surged more than 5% following its Q4 release, extending the 2023 rally to 100% and the gains since the 2020 lows to 250%, setting up an attractive selling

Caterpillar stock hits new highs; time to ring the register?: https://www.marketbeat.com/logos/articles/med_20240206085138_chart-cat-262024ver001.png
Caterpillar stock hits new highs; time to ring the register?

Caterpillar (NYSE: CAT) stock surged more than 5% following its Q4 release, extending the 2023 rally to 100% and the gains since the 2020 lows to 250%, setting up an attractive selling

5 medical stocks growing earnings by triple digits: https://www.marketbeat.com/logos/articles/med_20240206093532_5-medical-stocks-growing-earnings-by-triple-digits.jpg
5 medical stocks growing earnings by triple digits

While most of the market focuses on hyper-growth technology stocks rewarded by Wall Street as long as they mention the word "artificial intelligence" in their earnings calls, the reality is that

Peloton stock backpedals to a new low as shorts win: https://www.marketbeat.com/logos/articles/med_20240206092535_peloton-backpedals-to-a-new-low-as-shorts-win.jpg
Peloton stock backpedals to a new low as shorts win

A month ago, Peloton Interactive, Inc. (NASDAQ:PTON) rode news of a Tik Tok deal to a four-month high of $7.42. We wondered if the former pandemic high flier turned meme stock could keep up the

Palantir stock pops 20% and continues to silence skeptics: https://www.marketbeat.com/logos/articles/med_20240206092041_palantir-stock-pops-20-and-continues-to-silence-sk.jpg
Palantir stock pops 20% and continues to silence skeptics

Palantir Technologies Inc. (NYSE: PLTR) stock is up 20% in after-hours and pre-market trading after a strong earnings report. The company reported after the closing bell on February 5 and

3 small-cap biotechs with potential breakthroughs in 2024: https://www.marketbeat.com/logos/articles/med_20240206091213_3-small-cap-biotechs-with-potential-breakthroughs.jpg
3 small-cap biotechs with potential breakthroughs in 2024

There's a reason that many biotech investors prefer to stick with large-cap stocks. Investing in small-cap biotech stocks is not for risk-averse investors. Many are still clinical-stage companies

Alphabet triggers a sell-the-news reaction: Time to buy the dip?: https://www.marketbeat.com/logos/articles/med_20240204123355_charyt-googl.jpg
Alphabet triggers a sell-the-news reaction: Time to buy the dip?

Alphabet Inc. (NASDAQ: GOOGL) is a holding company that owns and operates a portfolio of enterprises, with Google being the main subsidiary. The computer and technology sector giant relies on

Alphabet triggers a sell-the-news reaction: Time to buy the dip?: https://www.marketbeat.com/logos/articles/med_20240204123355_charyt-googl.jpg
Alphabet triggers a sell-the-news reaction: Time to buy the dip?

Alphabet Inc. (NASDAQ: GOOGL) is a holding company that owns and operates a portfolio of enterprises, with Google being the main subsidiary. The computer and technology sector giant relies on

Alphabet triggers a sell-the-news reaction: Time to buy the dip?: https://www.marketbeat.com/logos/articles/med_20240204123355_charyt-googl.jpg
Alphabet triggers a sell-the-news reaction: Time to buy the dip?

Alphabet Inc. (NASDAQ: GOOGL) is a holding company that owns and operates a portfolio of enterprises, with Google being the main subsidiary. The computer and technology sector giant relies on

Is Humana’s pain HCA Healthcare’s gain?: https://www.marketbeat.com/logos/articles/med_20240204124713_chart-hca2.jpg
Is Humana’s pain HCA Healthcare’s gain?

HCA Healthcare Inc. (NYSE: HCA) is the largest for-profit hospital company in the United States. The company owns and operates 186 hospitals and nearly 2,400 ambulatory sites, including

Skechers stocks trips on inventory bloat, but there's an upside: https://www.marketbeat.com/logos/articles/med_20240204123210_charty-skx.jpg
Skechers stocks trips on inventory bloat, but there's an upside

Skechers U.S.A. Inc. (NYSE: SKX)  is a global lifestyle and performance footwear and apparel company that has really hit its stride in the last decade. The company’s shares recently hit all-time

This mid-cap tech stock just jumped 30%...and is still cheap: https://www.marketbeat.com/logos/articles/med_20240205142921_this-mid-cap-tech-stock-just-jumped-30.jpg
This mid-cap tech stock just jumped 30%...and is still cheap

The list of Silicon Valley’s hottest technology companies just got an unlikely addition in Sanmina Corporation (NASDAQ:SANM). Shares of the San Jose-based electronic manufacturing services (EMS)

3 companies that more than doubled analyst EPS estimates: https://www.marketbeat.com/logos/articles/med_20240204125241_chart-luv.jpg
3 companies that more than doubled analyst EPS estimates

Earnings season is well underway, and the winner-and-loser separation continues to grow. Of the companies that beat consensus analyst estimates, even fewer go well beyond and exceed analyst

Commvault launches to new highs; more highs to come: https://www.marketbeat.com/logos/articles/med_20240205093042_chart-cvlt-252024ver001.png
Commvault launches to new highs; more highs to come

Commvault Systems Inc. (NASDAQ: CVLT) is a less-covered, important cybersecurity stock with a rocketing share price. 

The story is a dual narrative, including the company's shift to cloud-based

3 chemical stocks to play the industry breakout: https://www.marketbeat.com/logos/articles/med_20240205183600_3-chemical-stocks-to-play-the-industry-breakout.jpg
3 chemical stocks to play the industry breakout

I hope you're the type of investor who will sit down and do the homework required to come out as a winner in the financial markets. When you do, you'll notice that the big guys at places like The

PepGen soars on Sarepta Therapeutics’ Duchenne drug phase 2 data: https://www.marketbeat.com/logos/articles/med_20240204123534_chart-pepg.jpg
PepGen soars on Sarepta Therapeutics’ Duchenne drug phase 2 data

PepGen Inc. (NASDAQ: PEPG) is a clinical-stage biotech focused on developing therapies for rare neuromuscular and neurological genetic diseases like Duchenne muscular dystrophy (DMD). PepGen

Eilt: Durchbruch in der Krebsforschung - Hautkrebs vollständig geheilt. Neuer 312% Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73505/AC-060224-2.001.png
Eilt: Durchbruch in der Krebsforschung - Hautkrebs vollständig geheilt. Neuer 312% Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Durchbruch in der Krebsforschung - Hautkrebs vollständig geheilt. 332% Biotech Hot Stock nach 9.290% mit Novo-Nordisk

 

06.02.24 08:02

AC Research

 

London (www.aktiencheck.de , Anzeige)

 

 

Eilt: Durchbruch in der Krebsforschung - Hautkrebs vollständig geheilt. Neuer 312% Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73505/AC-060224-2.001.png
Eilt: Durchbruch in der Krebsforschung - Hautkrebs vollständig geheilt. Neuer 312% Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Durchbruch in der Krebsforschung - Hautkrebs vollständig geheilt. 332% Biotech Hot Stock nach 9.290% mit Novo-Nordisk

 

06.02.24 08:02

AC Research

 

London (www.aktiencheck.de , Anzeige)

 

 

Eilt: Durchbruch in der Krebsforschung - Hautkrebs vollständig geheilt. Neuer 312% Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73505/AC-060224-2.001.png
Eilt: Durchbruch in der Krebsforschung - Hautkrebs vollständig geheilt. Neuer 312% Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Durchbruch in der Krebsforschung - Hautkrebs vollständig geheilt. 332% Biotech Hot Stock nach 9.290% mit Novo-Nordisk

 

06.02.24 08:02

AC Research

 

London (www.aktiencheck.de , Anzeige)

 

 

MarketBeat ‘Stock of the Week’: Driven Brands has road to recovery: https://www.marketbeat.com/logos/articles/med_20240205105130_marketbeat-stock-of-the-week-driven-brands-has-roa.png
MarketBeat ‘Stock of the Week’: Driven Brands has road to recovery

If you’re a car owner, there’s a good chance you’ve been to a Driven Brands Holdings Inc. (NASDAQ:DRVN) shop. 

As North America’s largest automotive services provider, the Charlotte-based company

Markets suddenly price Eli Lilly stock for a breakout on earnings: https://www.marketbeat.com/logos/articles/med_20240205101509_markets-suddenly-price-eli-lilly-stock-for-a-break.jpg
Markets suddenly price Eli Lilly stock for a breakout on earnings

Nowadays, the market sends mixed signals to virtually every investor attempting to participate today, squeezing out a few percentage points of gains from the stock movements. With the Federal

Markets suddenly price Eli Lilly stock for a breakout on earnings: https://www.marketbeat.com/logos/articles/med_20240205101509_markets-suddenly-price-eli-lilly-stock-for-a-break.jpg
Markets suddenly price Eli Lilly stock for a breakout on earnings

Nowadays, the market sends mixed signals to virtually every investor attempting to participate today, squeezing out a few percentage points of gains from the stock movements. With the Federal